• By Sarah Campian, MS, CGC
  • Posted April 21, 2026

The Gene Scene: TMEM127

Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…


  • By Sarah Campian, MS, CGC
  • Posted April 16, 2026

Leading the Shift to Proactive Care: The Christ Hospital’s High‑Risk Program Strategy

In the traditional healthcare model, cancer care is often reactive—a race against time that begins only after a diagnosis. But at The Christ Hospital Health Network, the goal is to flip that script. Under the leadership of Dr. Kevin Banks, Executive Director of Precision Health and Pharmacogenomics, the network is turning their focus to identifying…


  • By Charlie King, MGC, CGC
  • Posted April 14, 2026

The Gene Scene: HPDL

Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…


  • By Frankie Fann, MS, CGC
  • Posted April 9, 2026

A Hidden Cancer, Found in Time: One Patient’s CARE Journey

Germline genetic testing, also known as hereditary cancer testing, can reveal inherited risks for certain cancers long before symptoms appear. For many patients, this knowledge opens the door to proactive screening and early detection, when cancers may be easier to treat. By routinely assessing which patients may be at increased hereditary risk,…


  • By Grant Bonesteele, MS, CGC
  • Posted April 7, 2026

The Gene Scene: GAA

Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…


  • By Rachel Bluebond, MMSc, CGC
  • Posted March 24, 2026

The Gene Scene: SMAD4

Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…


  • By Haaniya Mallick, MS, CGC
  • Posted March 17, 2026

The Gene Scene: CASQ2

Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…


  • By Cassidy Janis, MS, CGC
  • Posted March 11, 2026

Making Waves with MAVES

From Uncertainty… Cassidy: When I met with my patient in late 2021, she had already faced bilateral breast cancer. First at age 52, and again in the other breast at age 55. In terms of family history, she only had a brother who was diagnosed with brain cancer and testicular cancer, so her family history didn’t indicate there was a strong…


  • By Katherine Crawford, MS, CGC
  • Posted March 10, 2026

The Gene Scene: CALM2

Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…


  • By Caitlin Reid, MS, LGC, CGC
  • Posted March 3, 2026

The Gene Scene: RB1

Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…